Suppr超能文献

ADP-核糖基化抑制剂可抑制从大鼠主动脉培养的平滑肌细胞的表型调节和增殖。

Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta.

作者信息

Thyberg J, Hultgårdh-Nilsson A, Kallin B

机构信息

Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.

出版信息

Differentiation. 1995 Nov;59(4):243-52. doi: 10.1046/j.1432-0436.1995.5940243.x.

Abstract

The effects of hexamethylenebisacetamide (HMBA), an inhibitor of poly-ADP-ribosylation, and meta-iodobenzylguanidine (MIBG), an inhibitor of mono-ADP-ribosylation, on the phenotypic properties and proliferation of cultured rat aortic smooth muscle cells were studied using a combination of structural and chemical methods. The results show that HMBA and MIBG both slowed down the transition of the cells from a contractile to a synthetic phenotype in primary culture. While the control cells rapidly lost most of their myofilaments and built up an extensive endoplasmic reticulum and Golgi complex, a conspicuous fraction of the drug-treated cells retained a characteristic smooth muscle morphology for at least 6 days. Moreover, most of the treated cells remained positive for smooth muscle alpha-actin and desmin throughout this period. In contrast, the drugs lacked distinct effects on cell morphology and cytoskeletal organization in secondary cultures. Nevertheless, they strongly inhibited serum-stimulated cell growth both in primary and secondary cultures. The ability of serum-starved cells to synthesize DNA after exposure to platelet-derived growth factor or serum was also restrained. Notably, the drugs could be added several hours after the mitogens without loss of effect, suggesting that they did not prevent the entrance into but rather the progression through the cell cycle. Accordingly, the expression of early response genes like c-fos, c-jun and c-myc was not blocked by the drugs. On the other hand, HMBA reduced the expression of transcripts for smooth muscle alpha-actin, type IV collagenase, collagen type I, and osteopontin both in primary and secondary cultures. Weaker and more variable effects were obtained with MIBG. Taken together, the findings support the notion that poly- and mono-ADP-ribosylation of proteins are involved in the control of smooth muscle cell differentiation and growth.

摘要

采用结构和化学方法相结合的方式,研究了聚 ADP 核糖基化抑制剂六亚甲基双乙酰胺(HMBA)和单 ADP 核糖基化抑制剂间碘苄胍(MIBG)对培养的大鼠主动脉平滑肌细胞表型特性和增殖的影响。结果表明,HMBA 和 MIBG 均减缓了原代培养细胞从收缩型向合成型表型的转变。对照细胞迅速丢失大部分肌丝并形成广泛的内质网和高尔基体复合体,而相当一部分经药物处理的细胞至少 6 天内保留了特征性的平滑肌形态。此外,在此期间,大多数处理过的细胞平滑肌α - 肌动蛋白和结蛋白仍呈阳性。相比之下,这两种药物对传代培养细胞的形态和细胞骨架组织没有明显影响。然而,它们在原代和传代培养中均强烈抑制血清刺激的细胞生长。血清饥饿细胞在暴露于血小板衍生生长因子或血清后合成 DNA 的能力也受到抑制。值得注意的是,在有丝分裂原作用数小时后添加药物仍有效果,这表明它们并非阻止细胞进入细胞周期,而是阻止细胞在细胞周期中的进展。因此,c - fos、c - jun 和 c - myc 等早期反应基因的表达并未被药物阻断。另一方面,HMBA 在原代和传代培养中均降低了平滑肌α - 肌动蛋白、IV 型胶原酶、I 型胶原蛋白和骨桥蛋白转录本的表达。MIBG 的作用较弱且更具变异性。综上所述,这些发现支持了蛋白质的多聚和单聚 ADP 核糖基化参与平滑肌细胞分化和生长调控的观点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验